2219.HK
Strong BuyFull HouseAI screen passChaoju Eye Care Holdings Limited · Healthcare · China · $211M
HKD 2.38 +0.6% · close 8 Oct · scored 9 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Read our full research report on 2219.HK (Jun 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Chaoju Eye Care maintains consistent profitability as an established ophthalmic hospital and clinical network operator in northern and eastern China. The stock trades at an undemanding valuation, complemented by recent open-market insider share purchases and an active share repurchase programme.
ABOUT CHAOJU EYE CARE HOLDINGS LIMITED
Read
Chaoju Eye Care Holdings Limited operates a rapidly expanding chain of private ophthalmic hospitals and optometry centers across China, offering comprehensive eye care services including cataract, refractive, and glaucoma treatments. The company leverages the increasing demand for specialized healthcare in China's tier-two and tier-three cities, establishing a strong regional market presence. Its competitive position is bolstered by a focus on advanced medical technologies and skilled practitioners within its growing network.
FINANCIAL SUMMARY (HKD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.2B | 1.6B | 1.6B | 1.6B | 11.2% | 1.6B | 1.8B | 15.0% |
| EPS (HKD) | 0.30 | 0.32 | 0.39 | 0.33 | 0.31 | 0.4% | 0.28 | 0.36 | 15.4% |
| Shares | — | 701.8M | 687.5M | 690.8M | 693.9M | -1.1% | 686.8M | — | — |
| Debt | — | 230.0M | 235.4M | 255.6M | 278.6M | 6.6% | 290.4M | — | — |
| Equity | — | 2.7B | 2.8B | 2.7B | 2.8B | 1.9% | — | — | — |
| Op CF | — | 320.6M | 436.8M | 415.5M | 397.9M | 7.5% | 388.9M | — | — |
| Inv CF | — | -544.9M | -766.9M | 287.7M | -540.0M | — | — | — | — |
| Fin CF | — | -193.9M | -239.2M | -342.7M | -155.8M | — | — | — | — |
Calmer than 82% of stocks we rank over the past year (25% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 2219.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 2219.HK | Chaoju Eye Care Holdings Limited(you) | $211M | 97 | Strong Buy |
| 2651.HK | Wuhan Dazhong Dental Medical Co., Ltd. | $221M | 94 | Strong Buy |
| 1526.HK | Rici Healthcare Holdings Limited | $167M | 98 | Strong Buy |
| 1515.HK | China Resources Medical Holdings Company Limited | $385M | 95 | Strong Buy |
| 2279.HK | Yonghe Medical Group Co., Ltd. | $128M | 100 | Strong Buy |
| 2120.HK | Wenzhou Kangning Hospital Co., Ltd. | $89M | 98 | Strong Buy |
| 2373.HK | Beauty Farm Medical and Health Industry Inc. | $588M | 96 | Strong Buy |
| 2677.HK | Distinct Healthcare Holdings Limited | $196M | 77 | Buy |
| 2273.HK | Gushengtang Holdings Limited | $741M | 97 | Strong Buy |
| 2508.HK | Saint Bella Group Limited | $230M | 59 | Hold |
Peer medians: ROE 4.3% · P/E 27.8x · Gross margin 53.0%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.